271 related articles for article (PubMed ID: 26211626)
1. The FHL2 regulation in the transcriptional circuitry of human cancers.
Cao CY; Mok SW; Cheng VW; Tsui SK
Gene; 2015 Nov; 572(1):1-7. PubMed ID: 26211626
[TBL] [Abstract][Full Text] [Related]
2. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
Wang Q; Wang X; Tian X; Tang R; Xu X
J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
[TBL] [Abstract][Full Text] [Related]
3. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
Matulis CK; Mayo KE
Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
[TBL] [Abstract][Full Text] [Related]
4. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
[TBL] [Abstract][Full Text] [Related]
5. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.
Kleiber K; Strebhardt K; Martin BT
Anticancer Res; 2007; 27(1A):55-61. PubMed ID: 17352216
[TBL] [Abstract][Full Text] [Related]
6. Identification of FHL2-regulated genes in liver by microarray and bioinformatics analysis.
Ng CF; Xu JY; Li MS; Tsui SK
J Cell Biochem; 2014 Apr; 115(4):744-53. PubMed ID: 24453047
[TBL] [Abstract][Full Text] [Related]
7. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the tumor suppressor FHL2 by p53 in human kidney and liver cells.
Xu J; Zhou J; Li MS; Ng CF; Ng YK; Lai PB; Tsui SK
PLoS One; 2014; 9(8):e99359. PubMed ID: 25121502
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
Jin X; Jiao X; Jiao J; Zhang T; Cui B
Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
[TBL] [Abstract][Full Text] [Related]
11. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
[TBL] [Abstract][Full Text] [Related]
12. The multifunctional roles of the four-and-a-half-LIM only protein FHL2.
Johannessen M; Møller S; Hansen T; Moens U; Van Ghelue M
Cell Mol Life Sci; 2006 Feb; 63(3):268-84. PubMed ID: 16389449
[TBL] [Abstract][Full Text] [Related]
13. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.
Chen YH; Wu ZQ; Zhao YL; Si YL; Guo MZ; Han WD
Chin Med J (Engl); 2012 Jul; 125(13):2329-33. PubMed ID: 22882857
[TBL] [Abstract][Full Text] [Related]
14. The roles of FHL2 in cancer.
Zhang J; Zeng Q; She M
Clin Exp Med; 2023 Nov; 23(7):3113-3124. PubMed ID: 37103649
[TBL] [Abstract][Full Text] [Related]
15. FHL2 protein is a novel co-repressor of nuclear receptor Nur77.
Kurakula K; van der Wal E; Geerts D; van Tiel CM; de Vries CJ
J Biol Chem; 2011 Dec; 286(52):44336-43. PubMed ID: 22049082
[TBL] [Abstract][Full Text] [Related]
16. The LIM-Only Protein Four and a Half LIM Domain Protein 2 Attenuates Development of Psoriatic Arthritis by Blocking Adam17-Mediated Tumor Necrosis Factor Release.
Leite Dantas R; Brachvogel B; Schied T; Bergmeier V; Skryabin B; Vogl T; Ludwig S; Wixler V
Am J Pathol; 2017 Nov; 187(11):2388-2398. PubMed ID: 28823868
[TBL] [Abstract][Full Text] [Related]
17. FHL2: a scaffold protein of carcinogenesis, tumour-stroma interactions and treatment response.
Verset L; Feys L; Trépant AL; De Wever O; Demetter P
Histol Histopathol; 2016 May; 31(5):469-78. PubMed ID: 26676939
[TBL] [Abstract][Full Text] [Related]
18. Four and a Half LIM Domains 2 (FHL2) Contribute to the Epithelial Ovarian Cancer Carcinogenesis.
Wang C; Lv X; He C; Davis JS; Wang C; Hua G
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092075
[TBL] [Abstract][Full Text] [Related]
19. Specific activation of PLEKHG2-induced serum response element-dependent gene transcription by four-and-a-half LIM domains (FHL) 1, but not FHL2 or FHL3.
Nishikawa M; Sato K; Nakano S; Yamakawa H; Nagase T; Ueda H
Small GTPases; 2019 Sep; 10(5):361-366. PubMed ID: 28489964
[TBL] [Abstract][Full Text] [Related]
20. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
